Are there any newer molecules for dyspepsia that do not pose long-term risks?

There are currently no newer molecules for dyspepsia that do not carry long-term risks. Proton pump inhibitors (PPIs) are still the first-line treatment for conditions such as esophagitis, ulcers, and reflux. It is recommended to periodically monitor therapy due to potential risks associated with their use.

Similar Questions

Is there a cream to soothe/heal hand, foot, and mouth?

General1 answer

I have a sore throat and there are white patches, what should I do?

General1 answer

My nail fell off after an injury, is there anything to do or will the nail eventually grow back?

General1 answer

Is there a problem with receiving a vaccine three days after sclerosing injections?

General1 answer

Is there anything to calm my cramps and gurgling?

General1 answer

Information provided by Medimap is for general purpose only and is not a substitute for medical advice. Click here to review our Terms of Service.

Back to QuestionsGeneral

Are there any newer molecules for dyspepsia that do not pose long-term risks?

There are currently no newer molecules for dyspepsia that do not carry long-term risks. Proton pump inhibitors (PPIs) are still the first-line treatment for conditions such as esophagitis, ulcers, and reflux. It is recommended to periodically monitor therapy due to potential risks associated with their use.